LanzaTech Advances Transformation with Leadership Changes and Cost Optimization Actions

(NASDAQ:LNZA),(NASDAQ:LNZAW), Chief Accounting Officer Sushmita Koyanagi promoted to Chief Financial Officer Deputy General Counsel Amanda Fuisz to assume Interim General Counsel role Cost savings and financial efficiencies drive continued advancement of commercial projects focused on producing alternative fuel from waste carbon CHICAGO, May 29, 2025 (GLOBE NEWSWIRE) — LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or […]

Amarillo College Graduate Rafael Aguirre’s Story Reaches Millions

Amarillo College Graduate Rafael Aguirre's Story Reaches Millions Viral Photo from Amarillo College Graduation Inspires GlobeNewswire May 29, 2025 AMARILLO, Texas, May 29, 2025 (GLOBE NEWSWIRE) — A photo of Rafael Aguirre, an 83-year-old lifelong learner, at Amarillo College's graduation May 9 has captured the hearts of more than 7 million people across multiple social

LanzaTech Advances Transformation with Leadership Changes and Cost Optimization Actions

LanzaTech Advances Transformation with Leadership Changes and Cost Optimization Actions GlobeNewswire May 29, 2025 Chief Accounting Officer Sushmita Koyanagi promoted to Chief Financial Officer Deputy General Counsel Amanda Fuisz to assume Interim General Counsel role Cost savings and financial efficiencies drive continued advancement of commercial projects focused on producing alternative fuel from waste carbon CHICAGO,

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

(TSX:LABS),(OTC US:MEDIF),(Other OTC:MEDIF),(Boerse Frankfurt – Freiverkehr:MLZ), TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company“), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed that the Company is aware of the news release issued by Apollo Technology Capital Corporation (“Apollo“) on May 29, 2025 making

Anal Cancer Market Heats Up Following Incyte’s Zynyz Greenlight | DelveInsight

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy and targeted therapies gain traction, competition will increase, raising the bar for efficacy and safety. The market is shifting toward personalized, less toxic treatments, creating opportunities for novel entrants but demanding strong

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Organon & Co.â?¯of Class Action Lawsuit And Upcoming Deadlines – OGN

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co.â?¯("Organon" or the "Company") (NYSE:OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Photronics, Inc. – PLAB

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. ("Photronics" or the "Company") (NASDAQ:PLAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Photronics and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eos Energy Enterprises, Inc. – EOSE

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Eos Energy Enterprises, Inc. ("Eos" or the "Company") (NASDAQ:EOSE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Eos and certain of its officers

BKKT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important June 2 Deadline in Securities Class Action – BKKT

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / WHY: New York, N.Y., May 29, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bakkt Holdings, Inc. (NYSE:BKKT) between March 25, 2024 and March 17, 2025, both dates inclusive (the "Class Period"), of the important June

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder

MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder GlobeNewswire May 29, 2025 TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (“MediPharm” or the “Company“), a pharmaceutical company specialized in precision-based cannabinoids, today confirmed that the Company is aware of the news release issued by Apollo Technology Capital

Scroll to Top